Br. Gabel et Ml. Koschinsky, ANALYSIS OF THE PROTEOLYTIC ACTIVITY OF A RECOMBINANT FORM OF APOLIPOPROTEIN(A), Biochemistry, 34(48), 1995, pp. 15777-15784
We have analyzed the proteolytic activity of a recombinant form of apo
lipoprotein(a) [r-apo(a)], A mutant 17-kringle form of r-apo(a) was en
gineered that contained a serine to arginine substitution which reinst
ates the tissue-type plasminogen activator (tPA) cleavage site in the
protease domain of r-apo(a), The mutant form of r-apo(a) was cleaved b
y tPA as determined by SDS-PAGE and fluorography and by Western blot a
nalysis, However, tPA cleavage did not result in an active protease as
both wildtype r-apo(a) and the mutant, either free or incorporated in
to r-Lp(a) particles, were uniformly inactive against a variety of chr
omogenic serine protease tripeptide substrates. To assess whether the
large number of kringle IV repeats present in apo(a) inhibits proteoly
tic activity, we generated truncated forms of the Ser-->Arg mutant con
taining one or 10 kringle IV repeats. These truncated versions of r-ap
o(a) were susceptible to cleavage by tPA but were inactive against the
plasmin substrate S-2251. Treatment of the Ser-->Arg mutant of the 17
-kringle r-apo(a) with tPA and diisopropylfluorophosphate (DFP) did no
t result in modification of the mutant protease domain by DFP. Finally
, we incubated r-apo(a) or r-Lp(a) particles formed in vitro with puri
fied human LDL; no degradation of LDL was observed after 16 h at 37 de
grees C. The results of this study suggest that one or more of the sub
stitutions present in the protease domain of apo(a), in addition to th
e Arg-->Ser substitution, render apo(a) proteolytically inactive.